Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-24-131098

Chief Financial Officer bought 15,000 shares at $0.59 ($8,850)

From the SEC's structured data for this filing

Trades in this filing

Howe Jill Ann · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-26 Purchase : show line 1 in the form +15,000 $0.59 $8,850 25,500 D
Open-market purchases · 15,000 sh · avg $0.59 · $8,850
Loading xslF345X05/ownership.xml…